| |
|
| |
| Links: |
Enzyme Linked Immunosorbent Assay (ELISA) is a powerful technique for detection and quantitation of biological substances such as protein, peptides, antibodies, and hormones. By combining the specificity of antibodies with the sensitivity of simple enzyme assay, ELISA can provide a quick and useful measurement of the concentration of an unknown antigen or antibody. The Boster Bio protocol for ELISA offers a step-by-step overview of the procedure. At Antibody-ELISA.com you will find all the information related to Elisa.
Currently, there are three major types of ELISA assays commonly used by researchers. They are: indirect ELISA, typically used for screening antibodies; sandwich ELISA protocol (or antigen capture), for analysis of antigen present; and competitive ELISA, for antigen specificity. PBL's IFN ELISA kits use the sandwich strategy.
The "sandwich" technique is so called because the antigen being assayed is held between two different antibodies each recognizing particular epitopes on the antigen. Because of both antibodies are specific for the target protein, this method can increase the assay specificity two to five times over other direct or indirect detection methods. In this method:
Elisa Troubleshooting is easy at Antibody-Elisa.com. ELISA is the gold standard of in vitro diagnostics (IVD) during the last five decades for analysis of biomarkers and important analyses in healthcare and diversified analytical settings. With over 300,000 peer-reviewed articles to date, ELISA-based technologies have open up a lucrative, commercial market. Despite ongoing developments in immunosensors, labs-on-chips, and microfluidic and point-of-care technologies, ELISA with high throughput and omnipotent nature has been unmatched in reliability for the monitoring and management of disease markers. It is still the most widely used immunoassay format by pharmaceutical industries for routine monitoring of drugs and drug impurities.
About Antibody-Elisa.com:
Modern medicine recognizes the complications of treating infectious diseases. It is realized that early diagnosis of diseases is extremely important these days.
Connecting particular proteins to specific disease continues to pose challenges to science even today, though a lot of developments have taken place in past. ELISA can be used to probe numerous diseases in several organisms. The ELISA is a simple test that produces dependable data in a short span of time. ELISA or Enzyme- link immunosorbent assay is the technique used to detect the presence of antibodies in the blood. In some instances, this test is not just for patience but also for plant pathology and quality control in various industries.
(Added: Mon Feb 11 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate ItThe global demand for bronchoscopes is projected to grow at a moderate annual rate till 2019, showcasing a 1.5x surge during 2018-2028. With a year-on-year growth rate of 4.3 percent in 2o19, the global bronchoscopes market is estimated to reach a valuation of US$ 441.4 Mn during the same period, as indicated in a recent report by Future Market Insights (FMI) on global bronchoscopes market. Increasing prevalence of chronic respiratory diseases including multiple respiratory and airway diseases, growing number of endoscopic surgeries, and early detection and diagnoses of critical conditions such as bronchopulmonary hemorrhage and chronic obstructive pulmonary diseases (COPD) are some key factors projected to further impact the sales of bronchoscopes in the coming years.
“Apart from the factors mentioned, technological advancements in the bronchoscopes landscape—witnessing a transformation shift from conventional invasive procedures to minimally invasive and advanced devices—is a critical factor determining the global demand for bronchoscopes, further amplifying its potential applications. White-light bronchoscopy, Navigational bronchoscopy, and Autofluorescence (blue-light) bronchoscopy among others are some notable advancements and development, driving the global demand for bronchoscopes. Moreover, thin bronchoscopes with minimally invasive features are also gaining prominence. Manufacturers of bronchoscopes have built upon original bronchoscopes by making advancements, in terms of applicability and product versatility”, explains a senior analyst of the company.
Top Four Manufacturers Contribute the Largest Global Revenue
Considering the growing rate of technological advancements key manufacturers of broncoscopes, are making significant investments in the research and development initiatives to further increase the product efficiency. The global broncoscopes market showcases a highly competitive landscape characterized by relatively high barriers to entry, differentiated and well established products, and notable high profit margins.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7965
Tier-1 manufacturers of bronchoscopes, including Olympus Corporation, FUJIFILM Holdings Corporation, Teleflex Incorporated, and HOYA Corporation, collectively hold a market share of approximately 62.5 percent—with Olympus Corporation contributing the largest revenue slice. Tier-2 players such as KARL STORZ GmbH & Co KG, Ambu A/S, and Richard Wolf GmbH and tier-3 players including Rochling Group and Shanghai AoHua Photoelectricity Endoscope Co., Ltd, collectively contribute approximately 37.5 percent revenue share to the global bronchoscopes market. Key forward market strategies include:
With continued improvements in the global healthcare setting, key players seek acquisition opportunities as a key growth strategy. Olympus Corporation, Fujifilm Holdings Corporation, Teleflex Incorporated, and HOYA Corporation are likely to focus on mergers, acquisitions, and collaborations strategies, in the coming years. HOYA Corporation, for instance, acquired C2 Therapeutics, to expand its interventional endoscopy offerings in the U.S. and also provide aftersales and repair services.
Besides strategic tie-ups, new product launches will continue to be the key differentiation strategy, helping manufacturers to further solidify their market position. For instance, Olympus Corporation launched Truresolution objectives for multiphoton laser scanning microscopes. Teleflex Incorporated launched LMA® Gastro™ Airway, facilitating airway control during endoscopic procedures.
Leading manufacturers of bronchoscopes are also focusing on geographical expansions, specifically in emerging nations, by acquiring local players in the endoscopy market.
Key Insights Drawn from Segmentation Analysis of the Bronchoscopes Market
On the basis of product type, video bronchoscopes are estimated to witness maximum traction. Holding an unrivaled market share of approximately 86.6 percent, video bronchoscopes sales is projected to generate nearly US$ 381.7 Mn in 2019. Utilizing the charge-coupled device (CCD) technology, video bronchoscopes can reach the
In terms of modality, flexible fiber bronchoscopes are indicated to hold a market share of nearly 93.7 percent. Single use flexible bronchoscopes will gain maximum traction, as per the report. Stringency in regulations coupled with elimination of cross-contamination risk are some key dynamics driving the demand for single use flexible bronchoscopes.
Asia Pacific is estimated to remain a high-revenue churning pocket, in the global bronchoscopes market. Improved access to healthcare services and rise in demand for quality healthcare, in addition to parallel need for improved user friendly products is expected to drive the sales of bronchoscopes in APAC. Moreover, focused regional expansion strategies implemented by key manufacturers of bronchoscopes, would bring further opportunities.
Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-7965
Critical Market Restrainers Identified
Risks of cross-contamination and post bronchoscopy infection in the form of bleeding, troubled breathing, and low blood oxygen level. FMI study indicates high infection rate at ambulatory surgical centers (ASCs), compared to clinics and hospitals.
Growing demand for non-invasive procedures including liquid biopsy and Magnetic Resonance Spectroscopy.
Stringency in regulations demanding a pre-market approval (PMA).
Future Market Insights (FMI) delivers key insights on the global hips & knees reconstructive market in its upcoming report titled “Hips & Knees Reconstructive Market: Global Industry Analysis (2012–2016) and Opportunity Assessment (2017 – 2027)”. In terms of revenue, the global hips & knees reconstructive market is projected to register a CAGR of 6.4% over the forecast period, owing to various factors regarding which FMI offers detailed insights and information in this report. A key trend witnessed in the global hips & knees reconstructive market is that manufacturers are focussing on new product innovations that are driving technological advancements, but are also cost effective. Globally, surgeons are adopting new minimally invasive surgical procedures, computer-navigated and robot-assisted surgical procedures, 3D printing technology and smart implants, which will have a significant impact on the overall growth of the global hips & knees reconstructive market.
Global Hips & Knees Reconstructive Market: Segmental Forecast
The global hips & knees reconstructive market is segmented based on product type, fixation type, end user and region. Based on product type, the market segmented into hip and knee reconstruction. The fixation type is segmented into cement, cementless and hybrid fixations. Total hip and knee reconstruction is the leading product type segment in the global hips & knees reconstructive market over the forecast period. The knee reconstruction segment is estimated to be valued at US$ 8,719.9 Mn by 2017 end and is projected to be valued at US$ 16,653.2 Mn by 2027 end, growing at a CAGR of 6.8% during the forecast period. The hip reconstruction segment is expected to be the second most lucrative segment in the global hips & knees reconstructive market, with an attractiveness index of 0.8 during the forecast period.
Based on fixation type, cementless fixation is the leading segment in the global hips & knees reconstructive market over the forecast period. The hybrid segment accounted for 28.1% value share in 2016 and is projected to account for 29.9% share by 2027 end. It is the second most attractive segment in the global hips & knees reconstructive market with an attractiveness index of 1.0 during the forecast period.
Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2717
By end user, the market is segmented into hospitals, orthopaedic clinics, and ambulatory surgical centres. Hospitals is the leading segment in the global hips & knees reconstructive market over the forecast period. Demand for hip and knee reconstruction is expected to be the highest in hospitals, and this segment is projected to register a CAGR of 6.1 % over the forecast period.
Global Hips & Knees Reconstructive Market: Regional Forecast
North America is expected to gain popularity over the forecast period, driven by an increasing geriatric population requiring hip and knee reconstruction. The North America market is predicted to dominate the global hips & knees reconstructive market, accounting for a maximum revenue share of the market by 2017 end. The North America, Western Europe, and Asia Pacific excluding Japan markets are collectively expected to account for around 79% of the global hips & knees reconstructive market value share by 2017 end. Revenue from the market in APEJ is estimated to expand at a CAGR of 6.8% over the forecast period.
Request to View TOC @ https://www.futuremarketinsights.com/askus/rep-gb-2717
Key Players
Some of the key hips & knees reconstructive market players covered in the report include Zimmer Biomet, Stryker, DePuy Companies (Sub. Johnson & Johnson Services, Inc.), Smith & Nephew Plc, Exactech, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, Limacorporate S.p.A., CeramTec, and ConforMIS. In this report, we have discussed the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways for players already present in the market and new players planning to enter the market.
(Added: Thu Feb 07 2019 Hits: 1 Rating: 0.00 Votes: 0) Rate ItPages: [<<] ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 ... [>>]
Links SQL By: Gossamer Threads Inc.